These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35247842)

  • 1. Establishment of human embryonic stem cell WAe009-A-74 carrying a Long QT syndrome mutation in KCNH2.
    Sun L; Zhong J; Wu F; Li F; Yang X; Zeng Z
    Stem Cell Res; 2022 Apr; 60():102725. PubMed ID: 35247842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a human embryonic stem cell line (WAe009-A-43) carrying a Long QT syndrome related mutation in KCNH2 gene.
    Wu X; Zhao Y; Wang X
    Stem Cell Res; 2020 Oct; 48():101976. PubMed ID: 32911324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of human embryonic stem cell WAe009-A-88 carrying a long QT syndrome mutation in KCNH2.
    Wen H; Sun L; Zhong J; Wu F
    Stem Cell Res; 2022 Jul; 62():102795. PubMed ID: 35526388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of human embryonic stem cell WAe009-A-48 carrying a long QT syndrome mutation in SCN5A.
    Yang X; Wu F; Zhong J; Li F
    Stem Cell Res; 2021 Mar; 51():102194. PubMed ID: 33517120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation.
    Chang Y; Li YN; Bai R; Wu F; Ma S; Saleem A; Zhang S; Jiang Y; Dong T; Guo T; Hang C; Lu WJ; Jiang H; Lan F
    Stem Cell Res Ther; 2021 May; 12(1):278. PubMed ID: 33962658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.
    Guo F; Sun Y; Wang H; Wang H; Zhou J; Fan H; Su J; Gong T; Jiang C; Liang P
    Stem Cell Res; 2022 Jul; 62():102813. PubMed ID: 35569348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
    Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
    Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1.
    Wang H; Guo T; Lan F
    Stem Cell Res; 2023 Aug; 70():103119. PubMed ID: 37244124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant.
    Zhao J; Wang L; Zhu K; Chen X; Qin F; Li X; Dong J; Tao H
    Stem Cell Res; 2022 Aug; 63():102836. PubMed ID: 35700634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.
    Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aborted Cardiac Arrest in LQT2 Related to Novel
    Bileišienė N; Barysienė J; Mikštienė V; Preikšaitienė E; Marinskis G; Keževičiūtė M; Utkus A; Aidietis A
    Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2
    Ono M; Burgess DE; Schroder EA; Elayi CS; Anderson CL; January CT; Sun B; Immadisetty K; Kekenes-Huskey PM; Delisle BP
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32759882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
    O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
    Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
    Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted next generation sequencing revealed a novel deletion-frameshift mutation of KCNH2 gene in a Chinese Han family with long QT syndrome: A case report and review of Chinese cases.
    Du F; Wang G; Wang D; Su G; Yao G; Zhang W; Su G
    Medicine (Baltimore); 2020 Apr; 99(16):e19749. PubMed ID: 32311972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
    Mura M; Mehta A; Ramachandra CJ; Zappatore R; Pisano F; Ciuffreda MC; Barbaccia V; Crotti L; Schwartz PJ; Shim W; Gnecchi M
    Int J Cardiol; 2017 Aug; 240():367-371. PubMed ID: 28433559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation in KCNH2 yields loss-of-function of hERG potassium channel in long QT syndrome 2.
    Gu K; Qian D; Qin H; Cui C; Fernando WCHA; Wang D; Wang J; Cao K; Chen M
    Pflugers Arch; 2021 Feb; 473(2):219-229. PubMed ID: 33449212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.
    Lahti AL; Kujala VJ; Chapman H; Koivisto AP; Pekkanen-Mattila M; Kerkelä E; Hyttinen J; Kontula K; Swan H; Conklin BR; Yamanaka S; Silvennoinen O; Aalto-Setälä K
    Dis Model Mech; 2012 Mar; 5(2):220-30. PubMed ID: 22052944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mutation L69P in the PAS domain of the hERG potassium channel results in LQTS by trafficking deficiency.
    Jenewein T; Kanner SA; Bauer D; Hertel B; Colecraft HM; Moroni A; Thiel G; Kauferstein S
    Channels (Austin); 2020 Dec; 14(1):163-174. PubMed ID: 32253972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.